Get the Stockscreener App
30.05
4.16%
1.20
After Hours:
30.05
Claritev Corp stock is traded at $30.05, with a volume of 101.13K.
It is up +4.16% in the last 24 hours and down -29.86% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$28.85
Open:
$29.03
24h Volume:
101.13K
Relative Volume:
0.47
Market Cap:
$496.60M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.03%
1M Performance:
-29.86%
6M Performance:
-29.59%
1Y Performance:
+0.00%
1-Day Range:
$29.03
$31.56
1-Week Range:
$28.14
$31.93
52-Week Range:
$16.38
$74.07
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
30.05 | 476.76M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
Claritev partners with Kinetiq Health to tackle high-cost healthcare claims - Investing.com Nigeria
Claritev (CTEV) Enters Strategic Partnership with Kinetiq Health - GuruFocus
Data deal targets small set of costly claims driving employers’ health bills - Stock Titan
Claritev : and Kinetiq Health enter into strategic agreement to strengthen cost management and advance claims surveillance and diagnostic certainty - marketscreener.com
Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Lobbying Update: $150,000 of CLARITEV (FORMERLY MULTIPLAN CORPORATION) lobbying was just disclosed - Quiver Quantitative
CTEV: Transformation, tech investment, and client focus drive growth and innovation in healthcare - TradingView — Track All Markets
Claritev outlines long-term growth strategy at healthcare conference - TipRanks
Claritev Corp Releases Investor Presentation at Healthcare Conference - TradingView — Track All Markets
Claritev: The Middleman In A Vertically Integrated Market (NYSE:CTEV) - Seeking Alpha
Claritev (CTEV) Price Target Decreased by 26.64% to 66.10 - Nasdaq
Aug Volume: What is Claritev Corporations P E ratio telling us2025 Macro Impact & Verified Short-Term Trading Plans - baoquankhu1.vn
Chipmakers Recap: How Claritev Corporation stock reacts to bond yieldsJuly 2025 Macro Moves & Consistent Return Investment Signals - Bộ Nội Vụ
Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target - marketscreener.com
Guggenheim initiates coverage on Claritev stock with Buy rating By Investing.com - Investing.com UK
Guggenheim initiates coverage on Claritev stock with Buy rating - Investing.com
175,767 Options of Claritev Corporation are subject to a Lock-Up Agreement Ending on 12-JAN-2026. - marketscreener.com
Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates - MSN
Claritev announces pricing of 1.5 million share secondary offering at $51.50 a piece - MSN
Why Claritev Corporation stock could rally in 20252025 Volatility Report & Daily Stock Trend Reports - Улправда
Does Claritev Corporation stock trade at a discount to peersTrend Reversal & AI Forecasted Entry/Exit Points - Улправда
Wells Fargo Initiates Coverage of Claritev (CTEV) with Equal-Weight Recommendation - Nasdaq
Claritev (CTEV): Citigroup Lowers Price Target while Maintaining Buy Rating | CTEV Stock News - GuruFocus
Wells Fargo initiates Claritev stock with Equal Weight rating, $33 target - Investing.com Nigeria
Wells Fargo Initiates Coverage on CTEV with Equal-Weight Rating - GuruFocus
Claritev price target lowered to $63 from $80 at Citi - TipRanks
What Catalysts Are Reshaping The Claritev (CTEV) Narrative On Growth Versus Leverage Risks - Yahoo Finance
Claritev Corporation Class A Common Stock (NY: CTEV - FinancialContent
Why Claritev Corporation Class stock stays resilientMarket Activity Summary & Reliable Price Breakout Alerts - ulpravda.ru
Can Claritev Corporation stock withstand economic slowdownJuly 2025 PostEarnings & Stepwise Trade Signal Guides - ulpravda.ru
Claritev initiated with an Equal Weight at Wells Fargo - TipRanks
Why Claritev Corporation stock remains a top recommendationJuly 2025 Analyst Calls & Weekly High Conviction Ideas - Улправда
Sentiment Review: Does Claritev Corporation stock trade at a discount to peersIPO Watch & Fast Entry High Yield Tips - Улправда
Can Claritev Corporation stock weather global recessionJuly 2025 Trade Ideas & Growth Oriented Trading Recommendations - Улправда
Star TribuneClaritev Corporation Class A Common Stock (NYSE:CTEV) Stock Quote - FinancialContent
Claritev Corporation to Present at J.P. Morgan Healthcare Conference - 01net
MarketsMedicine Hat News - FinancialContent
Claritev Ends Former CEO’s Strategic Advisory Role - The Globe and Mail
Claritev Corp announces end of Dale White’s strategic advisor role By Investing.com - Investing.com Australia
Claritev Corp announces end of Dale White’s strategic advisor role - Investing.com
Claritev Corp Announces Termination of Strategic Advisor Role - TradingView — Track All Markets
Claritev Corporation (NYSE: CTEV) ends Dale White advisory role; he remains director - Stock Titan
Claritev Corporation (CTEV) Stock Analysis: A 99% Upside Beckons as Analysts Rally Behind Healthcare Innovator - DirectorsTalk Interviews
Aug Levels: How buybacks impact Claritev Corporation stock value2025 Trading Volume Trends & Fast Entry High Yield Tips - Улправда
How buybacks impact Claritev Corporation stock value2025 Big Picture & Reliable Entry Point Trade Alerts - Улправда
Why Claritev Corporation stock remains undervalued2025 Sector Review & Fast Entry High Yield Tips - Улправда
Claritev Corp Stock (CTEV) Financials Data
There is no financial data for Claritev Corp (CTEV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.15%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):